Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Transpire Bio
Transpire Bio’s ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
May 11, 2026
Transpire Bio Announces Opening of New Satellite R&D Facility in Shanghai, China
May 4, 2026
Transpire Bio Strengthens its Leadership Team with Appointment of Ewan Livesey as Head of Business Development
April 29, 2026
Transpire Bio Strengthens its Leadership Team with Appointment of LaDuane Clifton as Chief Financial Officer
February 24, 2026
Transpire Bio’s ANDA for Generic Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
January 27, 2026